Trading indicator
Fibonacci RetracementsBacktest results
| Position | Trades | Duration | Win rate | Win/loss | Avg win | Avg loss | Return |
| Long | 10 | 4.5 | 20% | 25% | 1.6% | -0.8% | -3.4% |
|---|---|---|---|---|---|---|---|
| Short | 5 | 4.2 | 40% | 67% | 1.9% | -3.2% | -5.9% |
Company
Indicator
| Code | Company | Date | Close | Change | Indicator | Value | Signal |
|---|
Trading Performance
Fibonacci Retracements
Score
-1.05
| Position | Trades | Duration | Win Rate | Win/Loss | Avg Win | Avg Loss | Return |
|---|---|---|---|---|---|---|---|
| LONG | 3 | 196.3 | 1.00% | % | 48.5% | % | 145.5% |
| SHORT | 4 | 47.8 | 0.00% | 0.00% | 0.0% | -12.6% | -50.4% |
Summary
Technical Analysis
Clinuvel Pharmaceuticals (CUV.AX)
Indicator:
FIBONACCI RETRACTION
Signal Strength: MEDIUM
Recommendation:
Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading position.
Clinuvel Pharmaceuticals (ASX:CUV) : The current Fibonacci Retraction levels are:
(23.61%) $26.88
(38.2%) $28.36
(50%) $29.55
(61.8%) $30.74
The current support levels are:
(78.6%) $32.44
(100%) $34.6
(138.2%) $38.46
(161.8%) $40.84
(261.8%) $50.94
(423.61%) $67.28
A Fibonacci retracement is a term used in technical analysis that refers to areas of support (price stops going lower) or resistance (price stops going higher). Fibonacci retracement levels use horizontal lines to indicate areas of support or resistance at the key Fibonacci levels before the trend continues in the original direction.
Calculation: Fibonacci Retracements:
1) Uptrend: C = B — (B — A) x N%;
2) Downtrend: C = B + (A — B) x N%;
3) Fibonacci Levels:
a) 23.61%;
b) 38.2%;
c) 50%;
d) 61.8%;
e) 78.6%;
f) 100%,
PROFILE: Clinuvel Pharmaceuticals (CUV.AX)
Stock Exchange: ASX
Company: Clinuvel Pharmaceuticals
Ticker Codes: | CUV.AX | ASX:CUV |
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing drugs for the treatment of a range of severe skin disorders. Its lead drug compound is SCENESSE, a medicinal photoprotective and repigmentation drug that has completed Phase II and III trials in the United States and Europe, which is used for the prevention of phototoxicity in adults with erythropoietic protoporphyria. The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue that acts as a potent skin protectant; and VLRX001, an addition to the family of melanocortin analogues, which provoke increased and prolonged cellular activity. It has operations in Europe, the United States, and Singapore. The company is headquartered in Melbourne, Australia.
Top 10:
Fibonacci Retracements
| Company | Close | Change(%) | Volume | Value | Signal |
|---|---|---|---|---|---|
| EPW ERM Power | 2.45 | 42.4 | 11,431,310 | 0.25 | BULLISH |
| VOC Vocus Communications | 3.2 | 9.6 | 4,642,431 | 2.46 | BULLISH |
| OML Ooh!Media | 2.93 | 9.3 | 2,328,774 | 0.59 | BULLISH |
| SDF Steadfast | 3.81 | 7 | 5,307,131 | 0.49 | BULLISH |
| WTC Wisetech Global | 32.89 | 6.9 | 2,316,433 | 0.78 | BULLISH |
| ISD Isentia | 0.31 | 6.9 | 1,682,473 | 0.24 | BULLISH |
| MCY Mighty River Power | 5.05 | 6.8 | 10,062 | 0.45 | BULLISH |
| URF Us Masters Residential Property Fund | 0.8 | 6.7 | 48,505 | 1.76 | BULLISH |
| CCL Coca-Cola Amatil | 11.05 | 5.8 | 4,563,232 | 0.08 | BULLISH |
| CDD Cardno | 0.96 | 5.5 | 177,614 | 0.39 | BULLISH |